What's new? Log in Free sign up

Filing search / Kineta, Inc. / "Environment"

Search information

Kineta, Inc.

Companies

"Environment"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

104 results

Newest first Best match first

KANT Kineta, Inc.

Quarterly report

headings in the documents that are incorporated by reference herein. Moreover, we operate in a very competitive and rapidly changing environment. New risks

8 Aug 24

4:00pm

KANT Kineta, Inc.

Quarterly report

headings in the documents that are incorporated by reference herein. Moreover, we operate in a very competitive and rapidly changing environment. New risks

15 May 24

4:05pm

KANT Kineta, Inc.

in the documents that are incorporated by reference herein. Moreover, we operate in a very competitive and rapidly changing environment. New risks … . The cellular environment in which solid tumor cells thrive is generally hostile to T cells due to factors such as the presence of immunosuppressive

21 Mar 24

4:06pm

KANT Kineta, Inc.

Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts

shareholder value Approved by the Board of Directors Based on the current financing environment, the Company implemented several immediate actions Reduction

KANT Kineta, Inc.

Kineta Announces Restructuring and Exploration of Strategic Alternatives

form or media (including, but not limited to, any Company property stored in a cloud environment or in your personal computer, USB drives or in any

Kineta Announces Restructuring and Exploration of Strategic Alternatives

Prospectus supplement

Shelf registration

3 Nov 23

4:25pm

yljuaej2yq5e3kbghxxr

Quarterly report

3 Nov 23

4:04pm

Kineta, Inc. Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Prospectus supplement for primary offering

lw6kiovjnhl3 n2ayw4g

Quarterly report

11 Aug 23

4:07pm

Prospectus supplement

ljvc8x17 l4egtdhdx1

Shelf registration

1 Jun 23

4:01pm

e0zjl90oa87ddimd

Quarterly report

11 May 23

5:22pm

Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

cl63flprg68b w0oqa

Prospectus supplement for primary offering

zaz862z7sdu4ehs

31 Mar 23

4:05pm

Kineta Completes Reverse Merger with Yumanity Therapeutics

Quarterly report

14 Nov 22

8:44am

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.